Gotham Asset Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,908
Closed -$200K 1583
2024
Q4
$200K Buy
+20,908
New +$200K ﹤0.01% 1371
2024
Q1
Sell
-10,797
Closed -$25.9K 1397
2023
Q4
$25.9K Hold
10,797
﹤0.01% 1320
2023
Q3
$36.7K Buy
+10,797
New +$36.7K ﹤0.01% 1302
2022
Q2
Sell
-13,685
Closed -$562K 1153
2022
Q1
$562K Buy
+13,685
New +$562K 0.02% 767
2021
Q4
Sell
-5,150
Closed -$258K 1163
2021
Q3
$258K Sell
5,150
-8,218
-61% -$412K 0.01% 888
2021
Q2
$842K Sell
13,368
-3,972
-23% -$250K 0.04% 527
2021
Q1
$1.61M Sell
17,340
-101
-0.6% -$9.38K 0.07% 337
2020
Q4
$1.56M Sell
17,441
-18,185
-51% -$1.63M 0.05% 405
2020
Q3
$3.68M Buy
35,626
+23,886
+203% +$2.47M 0.12% 237
2020
Q2
$928K Sell
11,740
-1,867
-14% -$148K 0.03% 578
2020
Q1
$787K Buy
13,607
+2,903
+27% +$168K 0.02% 613
2019
Q4
$577K Hold
10,704
0.01% 767
2019
Q3
$560K Buy
10,704
+2,347
+28% +$123K 0.01% 733
2019
Q2
$404K Buy
+8,357
New +$404K 0.01% 861
2019
Q1
Sell
-41,352
Closed -$2.45M 1183
2018
Q4
$2.45M Buy
41,352
+29,414
+246% +$1.74M 0.04% 456
2018
Q3
$786K Sell
11,938
-8,653
-42% -$570K 0.01% 656
2018
Q2
$1.04M Sell
20,591
-625
-3% -$31.6K 0.02% 588
2018
Q1
$1.12M Sell
21,216
-14,910
-41% -$785K 0.02% 597
2017
Q4
$1.68M Sell
36,126
-117,168
-76% -$5.45M 0.02% 516
2017
Q3
$6.2M Buy
153,294
+89,261
+139% +$3.61M 0.09% 323
2017
Q2
$2.17M Sell
64,033
-56,135
-47% -$1.9M 0.03% 502
2017
Q1
$3.49M Sell
120,168
-45,351
-27% -$1.32M 0.04% 464
2016
Q4
$5.44M Sell
165,519
-76,997
-32% -$2.53M 0.07% 366
2016
Q3
$7.65M Sell
242,516
-222,795
-48% -$7.03M 0.1% 287
2016
Q2
$13.1M Buy
465,311
+21,583
+5% +$607K 0.16% 215
2016
Q1
$16.1M Sell
443,728
-3,139
-0.7% -$114K 0.18% 186
2015
Q4
$17.9M Buy
+446,867
New +$17.9M 0.19% 170
2014
Q3
Sell
-221,928
Closed -$4.99M 1007
2014
Q2
$4.99M Sell
221,928
-36,832
-14% -$827K 0.06% 400
2014
Q1
$6.54M Buy
+258,760
New +$6.54M 0.1% 314